<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">EMBO J</journal-id>
<journal-id journal-id-type="iso-abbrev">EMBO J</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)1460-2075</journal-id>
<journal-id journal-id-type="publisher-id">EMBJ</journal-id>
<journal-id journal-id-type="hwp">embojnl</journal-id>
<journal-title-group>
<journal-title>The EMBO Journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">0261-4189</issn>
<issn pub-type="epub">1460-2075</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30348864</article-id>
<article-id pub-id-type="pmc">6236329</article-id>
<article-id pub-id-type="doi">10.15252/embj.2018100241</article-id>
<article-id pub-id-type="publisher-id">EMBJ2018100241</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A novel lysosome‐to‐mitochondria signaling pathway disrupted by amyloid‐β oligomers</article-title>
<alt-title alt-title-type="left-running-head">Andrés Norambuena <italic>et al</italic></alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="embj2018100241-cr-0001">
<name>
<surname>Norambuena</surname>
<given-names>Andrés</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2977-1709</contrib-id>
<address>
<email>an2r@virginia.edu</email>
</address>
<xref ref-type="aff" rid="embj2018100241-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2018100241-cr-0002">
<name>
<surname>Wallrabe</surname>
<given-names>Horst</given-names>
</name>
<xref ref-type="aff" rid="embj2018100241-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2018100241-cr-0003">
<name>
<surname>Cao</surname>
<given-names>Rui</given-names>
</name>
<xref ref-type="aff" rid="embj2018100241-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2018100241-cr-0004">
<name>
<surname>Wang</surname>
<given-names>Dora Bigler</given-names>
</name>
<xref ref-type="aff" rid="embj2018100241-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2018100241-cr-0005">
<name>
<surname>Silva</surname>
<given-names>Antonia</given-names>
</name>
<xref ref-type="aff" rid="embj2018100241-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2018100241-cr-0006">
<name>
<surname>Svindrych</surname>
<given-names>Zdenek</given-names>
</name>
<xref ref-type="aff" rid="embj2018100241-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="embj2018100241-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2018100241-cr-0007">
<name>
<surname>Periasamy</surname>
<given-names>Ammasi</given-names>
</name>
<xref ref-type="aff" rid="embj2018100241-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="embj2018100241-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2018100241-cr-0008">
<name>
<surname>Hu</surname>
<given-names>Song</given-names>
</name>
<xref ref-type="aff" rid="embj2018100241-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2018100241-cr-0009">
<name>
<surname>Tanzi</surname>
<given-names>Rudolph E</given-names>
</name>
<xref ref-type="aff" rid="embj2018100241-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2018100241-cr-0010">
<name>
<surname>Kim</surname>
<given-names>Doo Yeon</given-names>
</name>
<xref ref-type="aff" rid="embj2018100241-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="embj2018100241-cr-0011">
<name>
<surname>Bloom</surname>
<given-names>George S</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4781-7627</contrib-id>
<address>
<email>gsb4g@virginia.edu</email>
</address>
<xref ref-type="aff" rid="embj2018100241-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="embj2018100241-aff-0005">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="embj2018100241-aff-0006">
<sup>6</sup>
</xref>
</contrib>
</contrib-group>
<aff id="embj2018100241-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Biology</named-content>
<institution>University of Virginia</institution>
<named-content content-type="city">Charlottesville</named-content>
<named-content content-type="country-part">VA</named-content>
<country country="US">USA</country>
</aff>
<aff id="embj2018100241-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Biomedical Engineering</named-content>
<institution>University of Virginia</institution>
<named-content content-type="city">Charlottesville</named-content>
<named-content content-type="country-part">VA</named-content>
<country country="US">USA</country>
</aff>
<aff id="embj2018100241-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">W.M. Keck Center for Cellular Imaging</named-content>
<institution>University of Virginia</institution>
<named-content content-type="city">Charlottesville</named-content>
<named-content content-type="country-part">VA</named-content>
<country country="US">USA</country>
</aff>
<aff id="embj2018100241-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Genetics and Aging Research Unit</named-content>
<named-content content-type="organisation-division">MassGeneral Institute for Neurodegenerative Disease</named-content>
<named-content content-type="organisation-division">Harvard Medical School</named-content>
<institution>Massachusetts General Hospital</institution>
<named-content content-type="city">Charlestown</named-content>
<named-content content-type="country-part">MA</named-content>
<country country="US">USA</country>
</aff>
<aff id="embj2018100241-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Cell Biology</named-content>
<institution>University of Virginia</institution>
<named-content content-type="city">Charlottesville</named-content>
<named-content content-type="country-part">VA</named-content>
<country country="US">USA</country>
</aff>
<aff id="embj2018100241-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Department of Neuroscience</named-content>
<institution>University of Virginia</institution>
<named-content content-type="city">Charlottesville</named-content>
<named-content content-type="country-part">VA</named-content>
<country country="US">USA</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>
Corresponding author. Tel: +1 434 982 5809; E‐mail: <email>an2r@virginia.edu</email><break></break>
Corresponding author. Tel: +1 434 243 3543; E‐mail: <email>gsb4g@virginia.edu</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>11</month>
<year>2018</year>
</pub-date>
<volume>37</volume>
<issue>22</issue>
<issue-id pub-id-type="doi">10.1002/embj.v37.22</issue-id>
<elocation-id>e100241</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>30</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 EMBO <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:EMBJ-37-e100241.pdf" xlink:type="simple"></self-uri>
<abstract id="embj2018100241-abs-0001">
<title>Abstract</title>
<p>The mechanisms of mitochondrial dysfunction in Alzheimer's disease are incompletely understood. Using two‐photon fluorescence lifetime microscopy of the coenzymes, <styled-content style="fixed-case">NADH</styled-content> and <styled-content style="fixed-case">NADPH</styled-content>, and tracking brain oxygen metabolism with multi‐parametric photoacoustic microscopy, we show that activation of lysosomal mechanistic target of rapamycin complex 1 (<styled-content style="fixed-case">mTORC</styled-content>1) by insulin or amino acids stimulates mitochondrial activity and regulates mitochondrial <styled-content style="fixed-case">DNA</styled-content> synthesis in neurons. Amyloid‐β oligomers, which are precursors of amyloid plaques in Alzheimer's disease brain and stimulate <styled-content style="fixed-case">mTORC</styled-content>1 protein kinase activity at the plasma membrane but not at lysosomes, block this Nutrient‐induced Mitochondrial Activity (Ni<styled-content style="fixed-case">MA</styled-content>) by a mechanism dependent on tau, which forms neurofibrillary tangles in Alzheimer's disease brain. Ni<styled-content style="fixed-case">MA</styled-content> was also disrupted in fibroblasts derived from two patients with tuberous sclerosis complex, a genetic disorder that causes dysregulation of lysosomal <styled-content style="fixed-case">mTORC</styled-content>1. Thus, lysosomal <styled-content style="fixed-case">mTORC</styled-content>1 couples nutrient availability to mitochondrial activity and links mitochondrial dysfunction to Alzheimer's disease by a mechanism dependent on the soluble building blocks of the poorly soluble plaques and tangles.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="embj2018100241-kwd-0001">Alzheimer's disease</kwd>
<kwd id="embj2018100241-kwd-0002">amyloid‐β oligomers</kwd>
<kwd id="embj2018100241-kwd-0003">mitochondria</kwd>
<kwd id="embj2018100241-kwd-0004">
<styled-content style="fixed-case">mTOR</styled-content>
</kwd>
<kwd id="embj2018100241-kwd-0005">tau</kwd>
</kwd-group>
<kwd-group kwd-group-type="subject-categories">
<title>Subject Categories</title>
<kwd>Autophagy &amp; Cell Death</kwd>
<kwd>Metabolism</kwd>
<kwd>Neuroscience</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>HHS|National Institutes of Health (NIH)</funding-source>
<award-id>RF1 AG051085</award-id>
<award-id>RF1 AG048080</award-id>
<award-id>R01 AG014713</award-id>
<award-id>S10 OD016446</award-id>
<award-id>R21 AG052062</award-id>
<award-id>P01 AG015379</award-id>
</award-group>
<award-group>
<funding-source>BrightFocus Foundation (BrightFocus)</funding-source>
</award-group>
<award-group>
<funding-source>Owens Family Foundation</funding-source>
</award-group>
<award-group>
<funding-source>Alzheimer's Association</funding-source>
<award-id>ZEN‐16‐363266</award-id>
</award-group>
<award-group>
<funding-source>Cure Alzheimer's Fund (CAF)</funding-source>
</award-group>
<award-group>
<funding-source>Webb and Tate Wilson</funding-source>
</award-group>
<award-group>
<funding-source>Virginia Chapter of the Lady's Auxilliary of the Fraternal Order of Eagles</funding-source>
</award-group>
<award-group>
<funding-source>University of Virginia President's Fund for Excellence</funding-source>
</award-group>
<award-group>
<funding-source>Alzheimer's and Related Diseases Research Award Fund</funding-source>
<award-id>17‐5</award-id>
</award-group>
<award-group>
<funding-source>Webb and Tate Wilson</funding-source>
</award-group>
<award-group>
<funding-source>Virginia Chapter of the Lady's Auxiliary of the Fraternal Order of Eagles</funding-source>
</award-group>
<award-group>
<funding-source>University of Virginia President's Fund for Excellence</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="12"></fig-count>
<table-count count="0"></table-count>
<page-count count="18"></page-count>
<word-count count="11084"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>embj2018100241</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>15 November 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.1 mode:remove_FC converted:15.11.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="embj2018100241-cit-1001" publication-type="journal">
<source xml:lang="en"/>The EMBO Journal (<year>2018</year>) <volume>37</volume>: <elocation-id>e100241</elocation-id>
</mixed-citation>
</p>
<fn-group id="embj2018100241-ntgp-0001">
<fn id="embj2018100241-note-0001">
<p>See also: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15252/embj.2018100839">https://doi.org/10.15252/embj.2018100839</ext-link> (November 2018)</p>
</fn>
</fn-group>
</notes>
</front>
</article>
</pmc-articleset>